Tyler M. Thompson

Senior Advisor

Washington, D.C.
T +1.202.861.1571
F +1.202.861.1783

Overview

Tyler Thompson assists clients with regulatory, legislative and policy matters related to healthcare access to affordable pharmaceuticals and medical devices, and occupational and workplace safety. He was a top advisor to Senator Johnny Isakson and served in a number of positions in the United States Senate for over ten years, focusing primarily on healthcare and OSHA policy, as well as appropriations. Since leaving Capitol Hill in 2012, Tyler has served as a lead consultant to a diverse group of clients across numerous industries, including technology innovators, industrial manufacturers, pharmaceutical and medical device companies, nonprofit children’s hospitals, and major trade associations.

Through this work, Tyler forged strong relationships with key members and staff in House and Senate leadership, as well as relevant committees of jurisdiction in both chambers on both sides of the aisle and in the Administration. Tyler works thoughtfully in a bipartisan manner to bridge gaps between opposing viewpoints and employs a keen understanding of administrative and legislative procedures to provide informed strategic advice and effective execution on behalf of clients.

*Not an Attorney

Select Experience

  • Worked to reform Medicaid policy related to children’s healthcare needs through involvement in the Children’s Hospital Graduate Medical Education Reauthorization policy.
  • Represented clients in meetings and substantive work with OSHA and relevant committees on Capitol Hill to further their interests though regulatory and legislative processes.
  • Navigated policies and procedures while providing substantive work and strategic analysis of the Affordable Care Act for a key US Senator.
More »

Experience

  • Worked to reform Medicaid policy related to children’s healthcare needs through involvement in the Children’s Hospital Graduate Medical Education Reauthorization policy.
  • Represented clients in meetings and substantive work with OSHA and relevant committees on Capitol Hill to further their interests though regulatory and legislative processes.
  • Navigated policies and procedures while providing substantive work and strategic analysis of the Affordable Care Act for a key US Senator.
  • Collaborated with opposing viewpoints during discussions on the Hope Offered Through Principled and Ethical Stem Cell Research (HOPE) Act. Used strong communication to assist in development of policies that addressed interests of all parties on controversial topic.
  • Negotiated and compromised with opposing parties throughout development of the Drug Quality of Security Act.
  • Involved in development of legislative policies related to pharmaceutical and medical device industry, including the Prescription Drug User Fee Act, Medical Device User Fee Act, Animal Drug User Fee Act, Biologics Price and Competition Act, Pandemic and All-Hazards Preparedness Act, and Medicare Modernization Act. Used combined knowledge of policies and politics at play to advance specific interests while remaining sensitive to stances of opposing parties.
  • Advised Senators and healthcare industry clients on healthcare regulations and policies within the Department of Health and Human Services. Provided additional advice on healthcare issues concerning, among other things, CDC and NIH budget formulation and appropriations and OMB policy.

Recognitions and Memberships

Industries

Prior Positions

  • The Bockorny Group: Principal and Healthcare Practice Lead (2012 to 2013)
  • Legislative Assistant for United States Senator Johnny Isakson (2005 to 2012)
  • Legislative Correspondent for United States Senator Saxby Chambliss (2005)
  • Legislative Correspondent for United States Senator Zell Miller (2002 to 2005)

Admissions

  • [Not an Attorney]

Education

  • B.A., History, Sewanee: The University of the South, 2002

Blog

In The Blogs

Previous Next
Ohio Clock
COVID-19 Legislative Response Phase 4
By Adam J. Higgins
April 1, 2020
Congress in March approved three separate major bills responding to the COVID-19 pandemic – and work was not even finished on the third and largest bill before lawmakers began considering a possible “Phase 4” of the legislative response...
Read More ->
Ohio Clock
CORONAVIRUS UPDATE: $1 Trillion Stimulus Next Up
By Christian B. Jones
March 19, 2020
The Senate is beginning to draft what likely will be the largest emergency relief and fiscal stimulus legislation in the country’s history – more than $1 trillion – to address the mushrooming coronavirus pandemic. The heart of the emerging...
Read More ->
Ohio Clock
COVID-19 Update: Congress' Risk to Public Companies
By Kevin R. Edgar
March 19, 2020
Companies large and small are scrambling to respond to the coronavirus pandemic, including understanding the emerging economic risks that could affect their profits, their operations and even their very existence. Add another burden to...
Read More ->
Ohio Clock
The Weekly Hill Update
March 9, 2020
Below is the Federal Policy team’s weekly preview, posted when Congress is in session. HEADLINES • After passing emergency funding to respond to the coronavirus, Washington is now turning to potential measures to bolster the economy – as...
Read More ->
Ohio Clock
Four Things to Know: What the Election Results Mean for Trade Policy
By Tyler M. Thompson
November 13, 2018
Democrats’ new majority in the House will bring the Trump administration’s past trade actions, as well as those under consideration, into sharper focus. Trade is shaping up to be a key issue heading into the 2020 election cycle, with...
Read More ->